Title : Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice.

Pub. Date : 1999 Aug

PMID : 10459570






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our previous studies have shown that the dopaminergic D1 receptor agonist SKF38393 (SKF) plus the D2 receptor agonist bromocriptine (BC) act synergistically to reduce obesity in obese C57BL/6J (ob/ob) mice. 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine dopamine receptor D1 Mus musculus
2 Our previous studies have shown that the dopaminergic D1 receptor agonist SKF38393 (SKF) plus the D2 receptor agonist bromocriptine (BC) act synergistically to reduce obesity in obese C57BL/6J (ob/ob) mice. 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine dopamine receptor D1 Mus musculus